Objective: To perform a cost-effectiveness analysis to evaluate preoperative use of mupirocin in patients with total joint arthroplasty (TJA).
Design: Simple decision tree model.
Setting: Outpatient TJA clinical setting.
Participants: Hypothetical cohort of patients with TJA.
Interventions: A simple decision tree model compared 3 strategies in a hypothetical cohort of patients with TJA: (1) obtaining preoperative screening cultures for all patients, followed by administration of mupirocin to patients with cultures positive for Staphylococcus aureus; (2) providing empirical preoperative treatment with mupirocin for all patients without screening; and (3) providing no preoperative treatment or screening. We assessed the costs and benefits over a 1-year period. Data inputs were obtained from a literature review and from our institution's internal data. Utilities were measured in quality-adjusted life-years, and costs were measured in 2005 US dollars.
Main Outcome Measure: Incremental cost-effectiveness ratio.
Results: The treat-all and screen-and-treat strategies both had lower costs and greater benefits, compared with the no-treatment strategy. Sensitivity analysis revealed that this result is stable even if the cost of mupirocin was over $100 and the cost of SSI ranged between $26,000 and $250,000. Treating all patients remains the best strategy when the prevalence of S. aureus carriers and surgical site infection is varied across plausible values as well as when the prevalence of mupirocin-resistant strains is high.
Conclusions: Empirical treatment with mupirocin ointment or use of a screen-and-treat strategy before TJA is performed is a simple, safe, and cost-effective intervention that can reduce the risk of SSI. S. aureus decolonization with nasal mupirocin for patients undergoing TJA should be considered.
Level Of Evidence: Level II, economic and decision analysis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1086/663704 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years" [J Hosp Infect 135 (2023) 55-58].
J Hosp Infect
January 2025
Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.
Antibiotic susceptibility and phenotypic profile of species isolated from different clinical samples from health facilities: A cross-sectional study.
SAGE Open Med
December 2024
Branch of Clinical Sciences, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq.
Background: species are widely distributed in nature and found in various human body sites.
Objectives: To determine the antibiotic susceptibility pattern of species isolated from different clinical samples.
Methods: This cross-sectional study was conducted on 400 clinical specimens from conveniently sampled patients seeking healthcare at two health facilities in sulaimani / Iraq.
Antimicrobial Resistance Profiles and Gene Characterization of Recovered from Facial Skin of Healthy Females in Shanghai, China.
Clin Cosmet Investig Dermatol
December 2024
School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, People's Republic of China.
Article Synopsis
- The study aimed to investigate antimicrobial resistance and gene characterization in facial skin samples from healthy women in Shanghai, China.
- Researchers collected samples from 107 females, isolating 94 unique bacterial strains, and tested their resistance to various antibiotics using standardized methods.
- Notable findings included a 23.4% resistance rate to oxacillin (indicating methicillin resistance), with several other antibiotics showing varying degrees of resistance, highlighting potential public health risks due to the prevalence of diverse resistance and virulence genes.
Secondary Myiasis in an Immunocompetent Patient With Severe Chromoblastomycosis.
Cureus
October 2024
Family Medicine, St. Joseph's Regional Medical Center, Paterson, USA.
This is the case of chronic chromoblastomycosis (CBM) in a 61-year-old male from the Dominican Republic (DR) with extensive cutaneous eruptions over multiple areas of the body including bilateral lower extremities and the flank extending to the back. A 61-year-old male with a history of morbid obesity, chronic kidney disease stage III, and well-controlled hypertension presented to the family medicine clinic for the evaluation of chronic painful skin lesions on his legs and torso. The lesions began 19 years prior, following a flood in the Dominican Republic (DR) where he was living at the time.
View Article and Find Full Text PDFSuccess rates of decolonisation treatment and risk factors for chronic carriage in methicillin-resistant throat carriers: a retrospective population-based cohort study.
Infect Dis (Lond)
November 2024
Department of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
Background: Throat carriage of methicillin-resistant (MRSA) has previously been associated with lower decolonisation treatment success rates.
Objectives: To characterise decolonisation treatment and outcome in Danish MRSA throat carriers.
Methods: This retrospective population-based cohort study included MRSA throat carriers between July, 2018 and June, 2019, in the Capital Region of Denmark.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!